Bottom line
QAAHBX vs JEHSX: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and JEHSX (Health Sciences Trust) are both etfs.
JEHSX is cheaper at 1.04% vs 1.11% — a difference of $7.00 a year per $10,000 invested.
Over five years, JEHSX returned +4.2% a year vs +3.9% for QAAHBX.
Updated Nov 19, 2026
QAAHBX vs JEHSX side by side
| QAAHBX | JEHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | T. Rowe Price | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 1.04% |
| Annual cost per $10k | $111 | $104 |
| 10-yr cost on $10k (prospectus) | $1,352 | $1,282 |
| Max front load | None | — |
| 12b-1 fee | 0.25% | 0.05% |
| 1-yr return | +17.8% | +19.5% |
| 5-yr return (annualized) | +3.9% | +4.2% |
| 10-yr return (annualized) | +8.7% | +8.7% |
| Best quarter | +23.4% | +23.6% |
| Worst quarter | −15.8% | −16.1% |
| Net assets (fund) | $751.7M | $251.3M |
| Number of holdings | 277 | 173 |
| Portfolio turnover | 65% | 68% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
23 of QAAHBX's top 25 holdings also appear in JEHSX's top 25.
| Holding | QAAHBX | JEHSX |
|---|---|---|
| Eli Lilly & Co | 14.06% | 14.30% |
| Johnson & Johnson | 6.64% | 6.33% |
| Unitedhealth Group Inc | 5.88% | 5.95% |
| Abbvie Inc | 5.12% | 5.28% |
| Merck & Co. Inc. | 4.00% | 4.21% |
| Gilead Sciences Inc | 2.79% | 2.95% |
| Thermo Fisher Scientific Inc | 2.53% | 2.67% |
| Vertex Pharmaceuticals Inc | 2.26% | 2.38% |
| Bristol-myers Squibb Co | 2.12% | 2.22% |
| Abbott Laboratories | 1.91% | 2.00% |
| Intuitive Surgical Inc | 1.89% | 1.98% |
| Amgen Inc | 1.80% | 1.90% |
| Stryker Corp | 1.78% | 1.87% |
| Elevance Health Inc | 1.54% | 1.63% |
| Danaher Corp | 1.44% | 1.51% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between QAAHBX and JEHSX?
QAAHBX (T. Rowe Price Health Sciences Portfolio) and JEHSX (Health Sciences Trust) are both etfs. JEHSX is cheaper at 1.04% vs 1.11% — a difference of $7.00 a year per $10,000 invested.
Which is cheaper, QAAHBX or JEHSX?
JEHSX has the lower expense ratio (1.04%).
Should I own both QAAHBX and JEHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.